Zobrazeno 1 - 10
of 21
pro vyhledávání: '"S, Jovtis"'
Autor:
Francisco Lastiri, Marcelo Muino, José Luis Castilla, S. Jovtis, Luis Balbiani, Mariana Abal, Roberto Pinckevicius, Adolfo Marantz, D. Lewi, Silvia Agusto, Eduardo Almira, Graciela Pasccon, Graciela Uranga, Luis Fein, Mónica Reale
Publikováno v:
Seminars in Oncology. 28:44-49
The primary goal of this phase II study was to determine the efficacy of gemcitabine (Gemzar; Eli Lilly and Company, Indianapolis, IN) plus 5-fluorouracil in patients with pancreatic cancer. Eligibility criteria included nonresectable locally advance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afdd06435c283d0bba23ac99a62798be
https://doi.org/10.1016/s0093-7754(01)80008-7
https://doi.org/10.1016/s0093-7754(01)80008-7
Autor:
E. Cazap, E. Triguboff, S. Breier, G. Uranga, M. R. Di Notto, L. Balbiani, A. Suarez, M. Trigo, G. Temperley, M.E. Pascual, F. Coppola, E. Mickiewicz, M. Rondinon, R. Estevez, S. Grasso, A. M. Bertoncin, D. Lewi, A. M. Alvarez, M. Ventriglia, C. Pazos, S. Jovtis
Publikováno v:
Breast Cancer Research and Treatment. 55:91-96
Purpose. To assess the response rate, survival, and toxicity of Taxol®(paclitaxel) as 1‐h infusion plus doxorubicin as first‐line treatment for patients with metastatic breast cancer (MBC). Patients and methods. Seventy‐six patients with untre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d4f659e0da689e1b3a674b8315d9519
https://doi.org/10.1023/a:1006194909859
https://doi.org/10.1023/a:1006194909859
Autor:
C, Pazos, E, Mickiewicz, M R, Di Notto, F, Cóppola, M, Ventriglia, S, Jovtis, L, Balbiani, D, Lewi, M, Róndinón, G, Témperley, M, Trigo, A M, Bertoncín, M, Pascual, G, Uranga, E, Cazap, S, Breier, S, Grasso, R, Estévez, E, Triguboff, A, Alvarez, A, Suárez
Publikováno v:
Breast cancer research and treatment. 55(1)
To assess the response rate, survival, and toxicity of Taxol (paclitaxel) as 1-h infusion plus doxorubicin as first-line treatment for patients with metastatic breast cancer (MBC).Seventy-six patients with untreated MBC were recruited. All of them ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1fcfa59bc39b548897eadb39b3d2b644
https://pubmed.ncbi.nlm.nih.gov/10472783
https://pubmed.ncbi.nlm.nih.gov/10472783
Autor:
E, Richardet, C, Pedraza, E, Mickiewicz, G, Lerzo, M, Bonamasa, F, Coppola, A, Elli, G, Uranga, S, Jovtis, M, Bruno, M, Ventriglia, M A, Cuevas, A M, Alvarez, L A, Suarez, L, Fein
Publikováno v:
Oncology (Williston Park, N.Y.). 13(7 Suppl 3)
Uracil and tegafur (in a molar ratio of 4:1 [UFT]) has proven activity against breast cancer and is delivered in an easy-to-administer oral formulation. Orzel, which combines UFT with the oral biomodulator, calcium folinate, may provide even greater
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f9e02e11b7413ee05484ed3cbbe75524
https://pubmed.ncbi.nlm.nih.gov/10442373
https://pubmed.ncbi.nlm.nih.gov/10442373
Autor:
M. Trigo, C Alasino, S. Jovtis, G Uranga, L Fein, D. Lewi, E. Mickiewicz, O De Cristófaro, C Delfino, G. Pascón, N Pilnik, M Abraham, F. Coppola, M. Ventriglia, L.A Suárez, Eduardo Richardet, S. Breier, Cuevas Ma, M Callejas
Publikováno v:
Lung Cancer. 29:74-75
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7576ec9bbe2876e3aa9937fe0fa027c6
https://doi.org/10.1016/s0169-5002(00)80241-x
https://doi.org/10.1016/s0169-5002(00)80241-x
Autor:
S. Jovtis, J Martinez, E. Almira, M Rondinon, M Orlando, D Maldonado, N Brocato, L Balbiani, M Bruno, G Cavarra, A.Z Comba, G Temperley
Publikováno v:
Lung Cancer. 29:46
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c673166d3bfa8c50fdbcb25ebb8b0a2a
https://doi.org/10.1016/s0169-5002(00)80150-6
https://doi.org/10.1016/s0169-5002(00)80150-6
Autor:
L. Balbiani, S. Jovtis, L. Castilla, R. Pinkevicius, A. Marantz, G. Uranga, G. Pascón, E. Almira, L. Fein, D. Lewi
Publikováno v:
European Journal of Cancer. 35:S157
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56aa689094af72acdf128e10c8fbf713
https://doi.org/10.1016/s0959-8049(99)81014-4
https://doi.org/10.1016/s0959-8049(99)81014-4
Autor:
E. Mickiewicz, D. Lewi, M. Trigo, R. Estevez, S. Jovtis, M. Ventnglia, M. Di Noto, S. Grasso, A. M. Bertoncin, S. Breier, G. Rubio, M. Rondinon, A. M. Alvarez, G. Temperley, M.E. Pascual, G. Uranga, C. Bas, E. Cazap
Publikováno v:
European Journal of Cancer. 33:S152
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86414ede86cfe17d9ac3f5176c95b5d1
https://doi.org/10.1016/s0959-8049(97)85265-3
https://doi.org/10.1016/s0959-8049(97)85265-3
Autor:
Federico Morera, Gladis Iparraguirre, Francisco Rao, Claudio Savulsky, María Picciola Marino, Jorge Carlevari, Héctor Graizer, Horacio Muro, Alicia Osuna, Gerardo Chiesa, Alfredo Larravide, Beatriz Dýaz, César Blajman, Justina Martínez, S. Jovtis, Adrián Longarte, Adelina Rufino, Cristián Federico, Isaac Fleischer, Carlos Ivulich, Juan Carlos Blanco Villalba, Ernesto Pasini Hansen, Carlos Rufino, Hugo Crego, Miguel Angel Chirino, Enrique Colombini, Beatriz De Núñez, Roberto Bianchi, Aldo Castagnari, Raúl Pensel, Adrián Hannois, Juan C. Cervellino, Carlos Cardoso, Daniel Levy, Graciela Pasccon, Mario F. Bruno, Simón Breier, Carlos Gálvez, Omar Fernández Giachella
Publikováno v:
Tumori Journal. 75:137-140
With the object of proving whether seqeuntial or alternate forms of chemotherapy would be advantageous one over the other in treating advanced breast cancer and with the purpose of evaluating two different anthracyclines at equimolecular doses in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49bb370dd5df9e7ea21ca7c085a9d74e
https://doi.org/10.1177/030089168907500211
https://doi.org/10.1177/030089168907500211
Autor:
O, Fernández Giachella, C, Gálvez, C, Rufino, A, Rufino, F, Morera, S, Jovtis, J C, Cervellino, H, Muro, H, Crego, M, Picciola Marino
Publikováno v:
Tumori. 75(2)
With the object of proving whether sequential or alternate forms of chemotherapy would be advantageous one over the other in treating advanced breast cancer and with the purpose of evaluating two different anthracyclines at equimolecular doses in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ffba7bc108288e427148c9b36732c603
https://pubmed.ncbi.nlm.nih.gov/2741219
https://pubmed.ncbi.nlm.nih.gov/2741219